Related Experiment Videos
Tendamistat as a scaffold for conformationally constrained phage peptide libraries
1Dupont-Merck Pharmaceutical Company, Experimental Station E328/B33, Wilmington, DE 19880-0328, USA.
Journal of Molecular Biology
|July 21, 1995
Summary
Researchers engineered bacteriophage M13 to display functional Tendamistat, a protein that inhibits alpha-amylase. This scaffold was used to create peptide libraries, successfully identifying novel binders to a specific antibody, demonstrating a new method for molecular discovery.
Area of Science:
- Biotechnology
- Protein Engineering
- Molecular Biology
Background:
- Tendamistat is a 74 amino acid beta-sheet protein from Streptomyces tendae with alpha-amylase inhibitory properties.
- Filamentous bacteriophage M13 can be engineered to display foreign proteins on its surface.
- Protein scaffolds offer potential for presenting diverse peptide libraries.
Purpose of the Study:
- To express functional Tendamistat on the surface of bacteriophage M13.
- To utilize displayed Tendamistat as a scaffold for presenting constrained random peptides.
- To select for novel binding molecules using phage display technology.
Main Methods:
- Expression of Tendamistat on M13 phage surface.
- Randomization of specific Tendamistat loops (residues 38-40 and 60-65) using PCR mutagenesis.
- Biopanning of mutant libraries against monoclonal antibody A8 (recognizing endothelin).
- Loop swapping and alanine replacement mutagenesis for binding site identification.
Main Results:
- Phage displaying Tendamistat demonstrated inhibition of alpha-amylase, confirming protein functionality.
- Engineered Tendamistat scaffolds successfully presented diverse random peptide libraries.
- Biopanning yielded phage clones that specifically bound to monoclonal antibody A8.
- Residues within the 60-65 loop of Tendamistat were identified as crucial for antibody binding.
Conclusions:
- Bacteriophage M13 can serve as a display platform for functional proteins like Tendamistat.
- Small, non-antibody protein scaffolds are effective for presenting constrained random peptides.
- This approach enables the selection of novel binding molecules, such as antibody binders.
- The study validates a method for generating targeted peptide libraries on protein scaffolds for molecular discovery.